Amgen Valuation
| AMG Stock | EUR 329.30 11.55 3.63% |
At this time, the firm appears to be overvalued. Amgen Inc shows a prevailing Real Value of €261.03 per share. The current price of the firm is €329.3. Our model approximates the value of Amgen Inc from analyzing the firm fundamentals such as current valuation of 214.61 B, and Price To Sales of 5.63 X as well as examining its technical indicators and probability of bankruptcy.
Price Book 23.7827 | Enterprise Value 214.6 B | Enterprise Value Ebitda 14.9518 | Price Sales 5.6333 | Forward PE 16.8067 |
Overvalued
Today
Please note that Amgen's price fluctuation is very steady at this time. Calculation of the real value of Amgen Inc is based on 3 months time horizon. Increasing Amgen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Amgen stock is determined by what a typical buyer is willing to pay for full or partial control of Amgen Inc. Since Amgen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amgen Stock. However, Amgen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 329.3 | Real 261.03 | Hype 330.83 | Naive 324.66 |
The intrinsic value of Amgen's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amgen's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amgen Inc helps investors to forecast how Amgen stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amgen more accurately as focusing exclusively on Amgen's fundamentals will not take into account other important factors: Amgen Cash |
|
About Amgen Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Amgen Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Amgen Inc based exclusively on its fundamental and basic technical indicators. By analyzing Amgen's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Amgen's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Amgen. We calculate exposure to Amgen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amgen's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 24.7 B | 22 B |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.